Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AECOMACM · Entity 3602 | Director | March 06, 2020 | March 10, 2020 |
| Accolade, Inc.ACCD · Entity 80959 | Director | June 16, 2021 | June 21, 2021 |
| Mirion Technologies, Inc.GSAH · Entity 394 | Director | August 13, 2020 | August 15, 2020 |
| SmileDirectClub, Inc.SDC · Entity 111962 | Director | May 12, 2021 | May 14, 2021 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 26, 2022 | May 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AECOM
Report date March 06, 2020 · Filed March 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,603 |
Reported balance
After 2020-03-06 transaction · row 1
1 source rowRow 1 · 2020-03-06 · Exercise / conversion · Acquired 5,245 · Balance 51,603 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-06 · Exercise / conversion · Disposed 5,245 · Balance 0 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock.
Accolade, Inc.
Report date June 16, 2021 · Filed June 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,895 |
Ending reported balance
After 2021-06-16 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,229 Row 2 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,479 Row 3 · 2021-06-16 · Exercise / conversion · Acquired 416 · Balance 302,895 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.50 · Expires 2027-07-26 | Direct | 500 |
Reported balance
After 2021-06-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 500 F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-05-02 | Direct | 2,750 |
Reported balance
After 2021-06-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 2,750 F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-07-25 | Direct | 5,834 |
Reported balance
After 2021-06-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-06-16 · Exercise / conversion · Disposed 416 · Balance 5,834 F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date.
F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date.
F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date.
Mirion Technologies, Inc.
Report date August 13, 2020 · Filed August 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Sponsor LLC InterestSEC Table II · derivative / convertible security | Direct | 35,000 |
Reported balance
After 2020-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-13 · Other · Acquired 35,000 · Balance 35,000 F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor
SmileDirectClub, Inc.
Report date May 12, 2021 · Filed May 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,241 |
Reported balance
After 2021-05-12 transaction · row 1
1 source rowRow 1 · 2021-05-12 · Purchase · Acquired 13,000 · Balance 64,241 |
Teladoc Health, Inc.
Report date May 26, 2022 · Filed May 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,726 |
Reported balance
After 2022-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 6,726 · Balance 6,726 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Disposition to issuer · Disposed 306,266 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2021 Filed Apr 6, 2021 01:08 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | GrantClass A Common Stock | 14,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001775625-21-000035 · wf-form4_161767118393552.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,241 F1 · shares: Comprised of Restricted Stock Units ("RSUs") that represent a contingent right to receive one share of the Issuer's Class A common stock. F2 · balance_after: The total number of shares of the Issuer's Class A common stock reported herein includes RSUs which were previously reported on Table II of that certain Form 4 filed by the reporting person on September 17, 2019. Further settlements of such RSUs will not be reported on further Forms 4. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,834 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · derivative · entry 6 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,750 Underlying: Common Stock · 1,834 shares Expires 2028-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option (including 8,999 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,250 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · derivative · entry 5 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option (including 7,750 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · derivative · entry 4 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,500 shares Expires 2027-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option (including 9,750 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 1,834 | $4.70 | $8,619.80 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · nonDerivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 1,250 | $4.70 | $5,875.00 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 11:31 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 1,500 | $4.50 | $6,750.00 |
DisclosureSEC source: 0001127602-21-008563 · form4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 22:52 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 657 | $27.39 | $17,995.23 |
DisclosureSEC source: 0001179110-21-001887 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,343 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 17:39 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 139,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006547 · doc4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,645 F1 · kind: Shares acquired by the Reporting Person through a distribution in-kind from Accretive Coinvestment Partners, LLC. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 20:45 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 804 | $22.38 | $17,993.52 |
DisclosureSEC source: 0001179110-20-010694 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,686 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-010004 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,350 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $208.50 | $154,290.00 |
DisclosureSEC source: 0001179110-20-010004 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-010004 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 20:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009907 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,090 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 20:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $200.89 | $148,658.60 |
DisclosureSEC source: 0001179110-20-009907 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 20:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009907 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009766 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,830 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $199.41 | $147,563.40 |
DisclosureSEC source: 0001179110-20-009766 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009766 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009621 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,570 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $196.78 | $145,617.20 |
DisclosureSEC source: 0001179110-20-009621 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009621 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 833 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · derivative · entry 6 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,584 Underlying: Common Stock · 833 shares Expires 2028-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option (including 8,166 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 750 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · derivative · entry 5 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 750 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option (including 7,000 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · derivative · entry 4 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 500 shares Expires 2027-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option (including 9,250 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 833 | $4.70 | $3,915.10 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · nonDerivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 750 | $4.70 | $3,525.00 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:16 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 500 | $4.50 | $2,250.00 |
DisclosureSEC source: 0001209191-20-049793 · doc4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009457 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,310 Underlying: Common Stock · 740 shares Expires 2014-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $217.50 | $160,950.00 |
DisclosureSEC source: 0001179110-20-009457 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009457 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009313 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,050 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $219.75 | $162,615.00 |
DisclosureSEC source: 0001179110-20-009313 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009313 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009125 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,790 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $192.50 | $142,450.00 |
DisclosureSEC source: 0001179110-20-009125 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-009125 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 15, 2020 01:01 UTC | Mirion Technologies, Inc. GSAH · Entity 394 | OtherSponsor LLC Interest · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-022510 · doc4.xml · derivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Class B Common Stock · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor F1 · kind: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor F1 · shares: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor F1 · derivative.exercise_date: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor F1 · derivative.expiration_date: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor F1 · balance_after: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008829 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,530 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $215.00 | $159,100.00 |
DisclosureSEC source: 0001179110-20-008829 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-008829 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008676 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,270 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $240.00 | $177,600.00 |
DisclosureSEC source: 0001179110-20-008676 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-008676 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,112 | $16.19 | $18,003.28 |
DisclosureSEC source: 0001179110-20-008602 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,882 F2 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008602 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,770 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 28, 2021, the first anniversary of the grant date. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 20:32 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008491 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,010 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 20:32 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 740 | $214.71 | $158,885.40 |
DisclosureSEC source: 0001179110-20-008491 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 20:32 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 740 | $6.01 | $4,447.40 |
DisclosureSEC source: 0001179110-20-008491 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2020 Filed Jul 20, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 740 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008374 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,750 Underlying: Common Stock · 740 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.